BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35980227)

  • 21. Subtype classification of hepatocellular adenoma.
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Hepatocellular Adenoma: Recent Advances.
    Agrawal S; Agarwal S; Arnason T; Saini S; Belghiti J
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1221-30. PubMed ID: 24909909
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
    Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
    Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of multiple hepatocellular adenomas after cessation of oral contraceptive pills: a case report and review of the current literature.
    Moors G; Poels H; Vandecaveye V; Roskams T; Verslype C
    Acta Gastroenterol Belg; 2021; 84(3):505-508. PubMed ID: 34599577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.
    Julien C; Le-Bail B; Ouazzani Touhami K; Frulio N; Blanc JF; Adam JP; Laurent C; Balabaud C; Bioulac-Sage P; Chiche L
    Ann Surg; 2021 Nov; 274(5):843-850. PubMed ID: 34334644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
    Cho SJ; Ferrell LD; Gill RM
    Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular adenoma: what we know, what we do not know, and why it matters.
    Bioulac-Sage P; Gouw ASH; Balabaud C; Sempoux C
    Histopathology; 2022 May; 80(6):878-897. PubMed ID: 34856012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
    Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular Adenomas: Morphology and Genomics.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
    Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
    Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
    Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
    J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management and outcome of hepatocellular adenoma with massive bleeding at presentation.
    Klompenhouwer AJ; de Man RA; Thomeer MG; Ijzermans JN
    World J Gastroenterol; 2017 Jul; 23(25):4579-4586. PubMed ID: 28740346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
    Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.
    Laurent A; Dokmak S; Nault JC; Pruvot FR; Fabre JM; Letoublon C; Bachellier P; Capussotti L; Farges O; Mabrut JY; Le Treut YP; Ayav A; Suc B; Soubrane O; Mentha G; Popescu I; Montorsi M; Demartines N; Belghiti J; Torzilli G; Cherqui D; Hardwigsen J;
    HPB (Oxford); 2016 Sep; 18(9):748-55. PubMed ID: 27593592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
    Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
    Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Henriet E; Abou Hammoud A; Dupuy JW; Dartigues B; Ezzoukry Z; Dugot-Senant N; Leste-Lasserre T; Pallares-Lupon N; Nikolski M; Le Bail B; Blanc JF; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
    Hepatology; 2017 Dec; 66(6):2016-2028. PubMed ID: 28646562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.
    Gordon SC; Reddy KR; Livingstone AS; Jeffers LJ; Schiff ER
    Ann Intern Med; 1986 Oct; 105(4):547-9. PubMed ID: 3019201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.